The Crick is a new type of biomedical research institute. Our uncompromising commitment to excellence, our emphasis on multidisciplinary research, our focus on young and emerging talent, our novel ways of partnership working, and our plans to export our best people to other institutions are some of the factors that will set the Crick apart.
The Crick aspires to be one of the world's leading medical research institutes. At the heart of our philosophy is a commitment to the highest quality science. We believe that the necessary quality can only be delivered through a focus on the best and most imaginative scientists, which in turn requires a broad and flexible approach to our scientific programme.
In building the new Francis Crick Institutes, the Crick partners' aim was to create a world-leading centre of biomedical research and innovation in the heart of London. Dedicated to research excellence, it has the scale, vision and expertise to tackle challenging scientific questions underpinning health and disease.
At the Crick we are passionate about our work and the benefits biomedical research can bring to people's health, the economy, and society. Our innovative and inclusive public engagement programme is designed to enlighten, inspire and entertain people of all ages and levels of understanding of science.
Caetano Reis e Sousa, a senior group leader at the Francis Crick Institute, has been named as a winner of the 2017 Louis-Jeantet Prize for Medicine. The European prize is awarded for fundamental biological research that is likely to have an impact in medicine and the treatment of disease.